Zeit Alert for Stroke at Home (ZASH) Protocol
ZASH
1 other identifier
observational
300
0 countries
N/A
Brief Summary
This is a single-arm, observational, feasibility study to evaluate if the Halo Alert System can be used in the future to detect stroke events in individuals at risk for stroke wearing the Halo Alert System overnight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2022
CompletedFirst Posted
Study publicly available on registry
December 30, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedDecember 30, 2022
December 1, 2022
1.5 years
December 11, 2022
December 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of Halo Alert System to collect EEG data for algorithm development
Subject's data collection with the Halo Alert System to assess the feasibility of EEG based stroke detection at home for algorithm development.
12 months enrollment period
Interventions
The Halo Alert System consists of an EEG sensor headband and is paired with a data transfer device.
Eligibility Criteria
The study population includes subjects who are 18 years of age or older with a new acute ischemic stroke confirmed by neuroimaging (CT or MRI scans) as the primary reason for hospital or clinic presentation during which screening took place.
You may qualify if:
- New ischemic stroke confirmed by neuroimaging (CT or MRI scans) as the reason for current hospital admission or stroke clinics visit. Time from ictus to enrollment should be ≤ 2 weeks;
- RRE-90 \> 2;
- Age ≥ 18 years old;
- Patient is discharged to home;
- Provision of signed and dated informed consent form.
You may not qualify if:
- Subject is a member of a vulnerable population, such as prisoners, individuals without legal papers, or otherwise exploitable population;
- Treatment with another investigational drug or intervention within the last two (2) weeks prior to start of this study, if said drug/intervention is expected to interfere with the normal function of the Halo Alert System;
- Does not have WIFI internet access in their home;
- Does not have access to a smartphone;
- Open traumatic injury on the head;
- Allergy to any of the components of the headband, such as the fabric of the band (88% Rayon, 9% Nylon, 3% Spandex), the electrode surfaces (conductive silver ink.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2022
First Posted
December 30, 2022
Study Start
January 1, 2023
Primary Completion
June 30, 2024
Study Completion
September 30, 2024
Last Updated
December 30, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share